MP Cancer Treatment Costs Jump 50% as Key Chemo Drugs Become Scarce

Top Summary

• What happened: Cancer treatment costs in Madhya Pradesh have risen by up to 50%, making each chemotherapy session ₹2,000-₹3,000 costlier. Prices of key drugs like Cisplatin and Carboplatin were increased by the NPPA, while supplies remain scarce.
• Why it matters: These platinum-based drugs are crucial, used in up to 70% of chemotherapy regimens, and are the most affordable option for many patients. Their shortage is forcing doctors to alter standard treatment methods.
• What changes: Patients face significantly higher overall treatment costs (thousands more per full cycle) and potential delays or changes to their prescribed chemotherapy plans due to drug unavailability.
• Who is affected: Cancer patients in Madhya Pradesh and potentially nationwide, particularly those from middle and low-income groups. Up to 70% of all cancer patients may be impacted by the shortage of essential medicines for 7 major cancer types.

Chemotherapy Costs Surge Across Madhya Pradesh

Cancer treatment expenses in Madhya Pradesh have escalated significantly, with costs rising by up to 50%. This surge translates to an additional ₹2,000-₹3,000 per chemotherapy session, burdening patients financially.

The National Pharmaceutical Pricing Authority (NPPA) approved price increases for Carboplatin and Cisplatin, two essential drugs. These are critical for treating common cancers including ovarian, lung, breast, and head-neck.

Experts highlight that patients typically require 4-6 or more chemo cycles, meaning the overall cost of treatment will increase by thousands of rupees.

Global Conflict Fuels Drug Shortages

The US-Iran conflict's impact extends beyond oil markets, now affecting cancer treatment in India. Disruptions in the supply chain caused by the conflict prompted pharmaceutical companies to halt production due to losses, leading to severe drug scarcity.

Cancer hospitals in Bhopal have reportedly run out of chemotherapy drugs. Manufacturers have resumed production, but supplies are expected to normalize only after approximately a month.

This critical shortage could affect up to 70% of cancer patients, particularly those needing essential medicines for 7 major types of cancer.

Doctors Adapt Amid Scarcity

The severe scarcity of platinum-based chemotherapy drugs like Cisplatin, Carboplatin, and Oxaliplatin is compelling doctors to change standard treatment methods. This disruption impacts patient care across the country, including government medical colleges and hospitals.

“A severe shortage of platinum-based chemotherapy drugs is affecting the treatment of cancer patients. Due to disruptions in the supply of essential drugs, doctors are having to change standard treatment methods,” stated Dr. Tushar Palve, Medical Superintendent of Cama and Albless Hospital in Mumbai.

While other chemotherapy drugs are available, the shortage of platinum-containing drugs still affects specific patients. There is a pressing need for domestic pharmaceutical companies to increase supply to alleviate the shortage and minimize treatment disruptions.

Critical Drugs See Price Hike Approval

The Central government has given in-principle approval to increase the prices of Cisplatin and Carboplatin, widely used chemotherapy drugs. This decision addresses both national shortages and rising production costs.

An official notification was issued on Friday, confirming price hikes ranging from 10% to 50%. This move aims to ensure drug availability and normalize production after assessing demand and manufacturing expenses.

The estimated 50% decrease in platinum-based chemo drug supply, primarily due to war and supply chain issues, severely impacted the availability and pricing of these crucial medicines.

Cisplatin: A Lifeline for Many

Cisplatin has been the most reliable and affordable drug for 20-30 years, essential for enhancing radiotherapy effects. It forms a long-established part of cancer treatment methodology.

According to Bhopal oncologist Dr. T.P. Sahoo, while Cisplatin costs thousands of rupees, its alternative, immunotherapy, can run into millions, making it unaffordable for common patients. This makes Cisplatin vital for middle and low-income groups.

Dr. O.P. Singh, former professor at Gandhi Medical College, Bhopal, highlighted that Cisplatin is used in approximately 70% of all chemotherapy regimens. Its broad application means its scarcity directly affects a vast number of patients.

Backbone of Cancer Treatment

Cisplatin and Carboplatin are recognized globally as indispensable chemotherapy drugs. They are foundational in treating various cancers, including lung, oral, cervical, ovarian, breast, testicular, and gallbladder cancers.

Oncologists consider these medicines a major part of first-line therapy for many malignancies. Both drugs fall under price control within the National List of Essential Medicines (NLEM) and DPCO.

The industry reported a significant gap between production costs and fixed selling prices, leading many companies to reduce or cease production. This imbalance necessitated the recent price adjustments to ensure continued supply.

What to Watch Next

Patients and healthcare providers will be closely monitoring the normalization of drug supplies, expected in about a month. Focus will also be on domestic pharmaceutical companies increasing production to stabilize availability and mitigate the financial and medical impact on countless cancer patients across India.